These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 19854140

  • 21. A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia.
    Zhang Y, Askenazi M, Jiang J, Luckey CJ, Griffin JD, Marto JA.
    Mol Cell Proteomics; 2010 May; 9(5):780-90. PubMed ID: 20019052
    [Abstract] [Full Text] [Related]

  • 22. Deregulation of signaling pathways in acute myeloid leukemia.
    Scholl C, Gilliland DG, Fröhling S.
    Semin Oncol; 2008 Aug; 35(4):336-45. PubMed ID: 18692684
    [Abstract] [Full Text] [Related]

  • 23. Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation.
    Razumovskaya E, Masson K, Khan R, Bengtsson S, Rönnstrand L.
    Exp Hematol; 2009 Aug; 37(8):979-89. PubMed ID: 19477218
    [Abstract] [Full Text] [Related]

  • 24. PKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling.
    Verbeek DS, Goedhart J, Bruinsma L, Sinke RJ, Reits EA.
    J Cell Sci; 2008 Jul 15; 121(Pt 14):2339-49. PubMed ID: 18577575
    [Abstract] [Full Text] [Related]

  • 25. Functional proteomics to identify critical proteins in signal transduction pathways.
    Yan GR, He QY.
    Amino Acids; 2008 Aug 15; 35(2):267-74. PubMed ID: 17704892
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.
    Abella JV, Park M.
    Am J Physiol Endocrinol Metab; 2009 May 15; 296(5):E973-84. PubMed ID: 19240253
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Phosphoproteomics, oncogenic signaling and cancer research.
    Chong PK, Lee H, Kong JW, Loh MC, Wong CH, Lim YP.
    Proteomics; 2008 Nov 15; 8(21):4370-82. PubMed ID: 18814326
    [Abstract] [Full Text] [Related]

  • 34. Insulin increase in MAP kinase phosphorylation is shifted to early time-points by overexpressing APS, while Akt phosphorylation is not influenced.
    Onnockx S, Xie J, Degraef C, Erneux C, Pirson I.
    Exp Cell Res; 2009 Sep 10; 315(15):2479-86. PubMed ID: 19527711
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Quantitative phosphoproteomics--an emerging key technology in signal-transduction research.
    Schreiber TB, Mäusbacher N, Breitkopf SB, Grundner-Culemann K, Daub H.
    Proteomics; 2008 Nov 10; 8(21):4416-32. PubMed ID: 18837465
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sprouty proteins, masterminds of receptor tyrosine kinase signaling.
    Cabrita MA, Christofori G.
    Angiogenesis; 2008 Nov 10; 11(1):53-62. PubMed ID: 18219583
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.